Skip to content

NVCR - NovoCure Ltd - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Novocure Ltd

NVCR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NVCRNovocure Ltd

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $21.45
52-wk low: $9.82
Prev close: $15.50
Mkt cap: $2.01B
Fwd P/E: 909.1x
Beta: 0.98

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$611.9M

JS
Jim Simons
Q2 2026 13F
$29.6M
position
AQ
AQR
Q2 2026 13F

Earnings

Reported Jul 23, 2026

Earnings came in 56.7% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -21.2%
Forward P/E: 909.09
Market cap: $2.0B

Valuation

P/S2.87
P/B6.03

Quality

Operating margin-5.8%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NVCR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $2.01B
Beta: 0.98

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

2.9x

P/B

6.0x

Profit margin

-21.2%

Op margin

-5.8%

ROE

-43.2%

$16.7M

position

DS

D.E. Shaw

Q2 2026 13F

$15.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NVCR

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.13+56.7%

-$0.30 expected

Next report

Reports Oct 29, 2026, in 69 days

EPS expected

-$0.33

-$0.40 to -$0.22

Revenue expected

$176.4M

7 analysts

Last 30 days

3up2down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

ROE

-43.2%

ROA-9.3%

Growth

Beta0.98